News
Avenzo Therapeutics has commenced the open-label Phase I/II trial of its CDK4 selective inhibitor, AVZO-023, for breast ...
Under the new law, anyone in Montana can legally access drugs that have passed just one phase 1 clinical trial.
Global IT services provider FPT and Pharma Group jointly hosted the Healthcare Innovation Forum - HIF 2025. The event served ...
Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.
A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...
Below is a list of U.S. regulators who oversee Musk's companies, including automaker Tesla, rocket and satellite company ...
There have been 258 placebo-controlled clinical trials of vaccines, according to a new research project. More than half of ...
Otsuka's investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with ...
- Selected to Attend In-Person Event on June 5 led by FDA Commissioner Marty A. Makary, M.D., M.P.H. - ...
Bayer Pharmaceuticals focuses on tiered pricing in India, emphasizing innovation, access to medicine, and global clinical ...
The risk US transportation, environmental, communications and other regulators will take aim at Elon Musk's many businesses ...
Dr. Radhakrishnan brings significant experience in product development and commercialization that will be particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results